1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine has been researched along with actinonin in 2 studies
Studies (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Trials (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Recent Studies (post-2010) (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Studies (actinonin) | Trials (actinonin) | Recent Studies (post-2010) (actinonin) |
---|---|---|---|---|---|
9 | 0 | 2 | 166 | 0 | 57 |
Protein | Taxonomy | 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (IC50) | actinonin (IC50) |
---|---|---|---|
Urokinase-type plasminogen activator | Homo sapiens (human) | 0.14 | |
Interstitial collagenase | Homo sapiens (human) | 1.1 | |
Neprilysin | Oryctolagus cuniculus (rabbit) | 8.2 | |
72 kDa type IV collagenase | Homo sapiens (human) | 3 | |
Stromelysin-1 | Homo sapiens (human) | 6 | |
Neprilysin | Homo sapiens (human) | 6.7 | |
Aminopeptidase N | Homo sapiens (human) | 0.4 | |
Peptide deformylase | Staphylococcus aureus subsp. aureus Mu50 | 0.005 | |
Peptide deformylase | Staphylococcus aureus | 0.02 | |
Peptide deformylase 1A, chloroplastic/mitochondrial | Arabidopsis thaliana (thale cress) | 0.027 | |
Peptide deformylase, mitochondrial | Homo sapiens (human) | 0.5622 | |
Peptide deformylase | Escherichia coli | 0.052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
2 other study(ies) available for 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine and actinonin
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |